Viking Therapeutics (NasdaqCM:VKTX) has experienced an 11% monthly decline in its stock price, a notable movement amid its recent announcements and a wider market downturn. The company completed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback